Alto Neuroscience Class Action Lawsuit Filed Against Officers.

A class action lawsuit has been filed against Alto Neuroscience, Inc. (NYSE: ANRO) and certain officers for alleged securities violations. The lawsuit claims that the company and its officers misled investors in its initial public offering and during the Class Period (February 2, 2024 to October 22, 2024). The plaintiff seeks to recover damages on behalf of investors who purchased Alto securities during this time.

Alto Neuroscience, Inc. (NYSE: ANRO) is facing a class action lawsuit alleging securities fraud. The lawsuit, filed by Levi & Korsinsky, LLP, claims that the company and its officers misled investors during the initial public offering and the subsequent class period from February 2, 2024, to October 22, 2024.

The complaint alleges that Alto Neuroscience, Inc. made false statements and concealed material information regarding its product pipeline, ALTO-100. Specifically, the company is accused of overstating the effectiveness of ALTO-100 in treating major depressive disorder, which led to an overestimation of the clinical, regulatory, and commercial prospects of the product. As a result, the lawsuit claims that Alto's business and financial prospects were also overstated, and the company's public statements were materially false and misleading.

The class action lawsuit seeks to recover losses on behalf of investors who purchased Alto common stock or other securities during the relevant time frame. Investors who believe they were adversely affected by the alleged securities fraud are encouraged to contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The deadline to request that the Court appoint you as lead plaintiff is September 19, 2025. Participation in the lawsuit is free of cost, and investors may be entitled to compensation without any out-of-pocket expenses.

Levi & Korsinsky, LLP has a proven track record in securities litigation, having secured hundreds of millions of dollars for aggrieved shareholders and ranking among the top firms in the United States for seven consecutive years [1][2].

References:
[1] https://www.morningstar.com/news/pr-newswire/20250902ny61586/levi-korsinsky-notifies-shareholders-of-alto-neuroscience-incanro-of-a-class-action-lawsuit-and-an-upcoming-deadline
[2] https://www.marketscreener.com/news/levi-korsinsky-notifies-shareholders-of-alto-neuroscience-inc-anro-of-a-class-action-lawsuit-an-ce7c50d3de8df721